Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Rhythm Pharmaceuticals Inc., 3 years.
Rhythm Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Amylyx Pharmaceuticals Inc. | Grant or award | +22,807 | — | — |
| Mar 5, 2026 | Amylyx Pharmaceuticals Inc. | Grant or award | +95,990 | — | — |
| Mar 2, 2026 | Amylyx Pharmaceuticals Inc. | Open-market sale | −6,461 | $14.58 | $94,201 |
| Dec 1, 2025 | Amylyx Pharmaceuticals Inc. | Open-market sale | −6,580 | $14.35 | $94,423 |
| Sep 30, 2025 | Amylyx Pharmaceuticals Inc. | Open-market sale | −12,039 | $14.58 | $175,529 |
| Jun 18, 2025 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,000 | — | — |
| Mar 31, 2025 | Amylyx Pharmaceuticals Inc. | Open-market sale | −12,425 | $3.47 | $43,115 |
| Mar 6, 2025 | Amylyx Pharmaceuticals Inc. | Grant or award | +68,420 | — | — |
| Dec 2, 2024 | Amylyx Pharmaceuticals Inc. | Open-market sale | −5,421 | $5.54 | $30,032 |
| Sep 30, 2024 | Amylyx Pharmaceuticals Inc. | Open-market sale | −11,442 | $3.20 | $36,614 |
| Jun 21, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +3,000 | — | — |
| Apr 16, 2024 | Amylyx Pharmaceuticals Inc. | Grant or award | +96,910 | — | — |
| Nov 27, 2023 | Amylyx Pharmaceuticals Inc. | Grant or award | +58,333 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.